MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidenceKarl‐Christian Bergmann, Jean Bousquet, S. Arnavielhe et al.|Clinical and Translational Allergy|2018Cited by 139
Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK studyAnnabelle Bédard, Aziz Sheikh, Xavier Basagaña et al.|Journal of Allergy and Clinical Immunology|2019Cited by 137
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthmaP. Schmidt‐grendelmeier, Ana Todo‐Bom, M. Illario et al.|Clinical and Translational Allergy|2019Cited by 131
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensusJan Hagemann, Neven Miculinić, Gabrielle L. Onorato et al.|Allergy|2021Cited by 72
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergyJean Bousquet, José E. Gereda, Oliver Pfaar et al.|Clinical and Translational Allergy|2021Cited by 59